A method for detecting hepatitis C envelope specific memory B cells from multiple genotypes using cocktail E2 tetramers.
E2-specific B cells
HCV
Monoclonal antibodies and hybridoma cells
Tetramer
Journal
Journal of immunological methods
ISSN: 1872-7905
Titre abrégé: J Immunol Methods
Pays: Netherlands
ID NLM: 1305440
Informations de publication
Date de publication:
09 2019
09 2019
Historique:
received:
14
03
2019
revised:
13
06
2019
accepted:
17
06
2019
pubmed:
22
6
2019
medline:
8
5
2020
entrez:
22
6
2019
Statut:
ppublish
Résumé
Hepatitis C (HCV) is a rapidly mutating RNA virus, with a strong propensity to cause chronic infection and progressive liver disease. Recent evidence has shown that early appearance of neutralizing antibodies in primary infection is associated with clearance. Little is known about the characteristics of HCV-specific B cells and their correlation with outcomes in primary infection, as there is a lack of sensitive tools for HCV-specific B cells which are present at very low frequency. We describe the development and optimisation of tetramer staining for flow cytometric detection of HCV-specific B cells using a cocktail of two recombinant HCV Envelope-2 (rE2) glycoproteins (from genotype 1a and 3a; Gt1a and Gt3a) and streptavidin dyes. The optimal weight to weight (w/w) ratio of streptavidin-phycoerythrin (PE) and rE2 proteins were determined for sensitive detection using HCV E2-specific hybridoma cell lines and peripheral blood mononuclear cells (PBMC) from HCV-infected individuals. In a cross-sectional set of PBMC samples collected from 33 subjects with either chronic infection or previous clearance, HCV E2-specific B cells (CD19
Identifiants
pubmed: 31226262
pii: S0022-1759(19)30068-7
doi: 10.1016/j.jim.2019.06.016
pii:
doi:
Substances chimiques
Viral Envelope Proteins
0
glycoprotein E2, Hepatitis C virus
157184-61-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
65-74Informations de copyright
Copyright © 2019. Published by Elsevier B.V.